Literature DB >> 35089341

Volumetric measurements in low-grade glioma: Are we there yet?

Elizabeth R Gerstner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35089341      PMCID： PMC9071325          DOI： 10.1093/neuonc/noac018

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  4 in total

1.  Interobserver variability in the radiological assessment of response to chemotherapy in glioma.

Authors:  M J Vos; B M J Uitdehaag; F Barkhof; J J Heimans; H C Baayen; W Boogerd; J A Castelijns; P H M Elkhuizen; T J Postma
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

2.  Impact of MRI head placement on glioma response assessment.

Authors:  Martin Reuter; Elizabeth R Gerstner; Otto Rapalino; Tracy T Batchelor; Bruce Rosen; Bruce Fischl
Journal:  J Neurooncol       Date:  2014-02-25       Impact factor: 4.130

3.  Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.

Authors:  Benjamin M Ellingson; Grace Hyun J Kim; Matt Brown; Jihey Lee; Noriko Salamon; Lori Steelman; Islam Hassan; Shuchi S Pandya; Saewon Chun; Michael Linetsky; Bryan Yoo; Patrick Y Wen; Ingo K Mellinghoff; Jonathan Goldin; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

4.  Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement.

Authors:  Ken Chang; Andrew L Beers; Harrison X Bai; James M Brown; K Ina Ly; Xuejun Li; Joeky T Senders; Vasileios K Kavouridis; Alessandro Boaro; Chang Su; Wenya Linda Bi; Otto Rapalino; Weihua Liao; Qin Shen; Hao Zhou; Bo Xiao; Yinyan Wang; Paul J Zhang; Marco C Pinho; Patrick Y Wen; Tracy T Batchelor; Jerrold L Boxerman; Omar Arnaout; Bruce R Rosen; Elizabeth R Gerstner; Li Yang; Raymond Y Huang; Jayashree Kalpathy-Cramer
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.